Get the Stockscreener App
4.30
0.92%
-0.04
Siga Technologies Inc stock is traded at $4.30, with a volume of 347.34K.
It is down -0.92% in the last 24 hours and up +3.12% over the past month.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
See More
Previous Close:
$4.34
Open:
$4.33
24h Volume:
347.34K
Relative Volume:
0.57
Market Cap:
$308.41M
Revenue:
$94.57M
Net Income/Loss:
$23.28M
P/E Ratio:
13.26
EPS:
0.3242
Net Cash Flow:
$43.12M
1W Performance:
-2.05%
1M Performance:
+3.12%
6M Performance:
-31.53%
1Y Performance:
-33.85%
1-Day Range:
$4.28
$4.34
1-Week Range:
$4.255
$4.42
52-Week Range:
$4.095
$9.62
Siga Technologies Inc Stock (SIGA) Company Profile
Name
Siga Technologies Inc
Sector
Phone
212-672-9100
Address
31 EAST 62ND STREET, NEW YORK, NY
Compare SIGA vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SIGA
Siga Technologies Inc
|
4.30 | 311.28M | 94.57M | 23.28M | 43.12M | 0.3242 |
TAK
Takeda Pharmaceutical Co Adr
|
15.66 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.09 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.91 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
79.33 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
548.27 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Siga Technologies Inc Stock (SIGA) Latest News
SIGA SEC FilingsSiga Technologie 10-K, 10-Q, 8-K Forms - Stock Titan
SIGA Technologies (SIGA) director reshapes holdings with RSU exercise - Stock Titan
SIGA Technologies held 2026 annual meeting; director/officer changes disclosed - TradingView
SIGA Technologies (SIGA) investors approve 15M-share stock incentive plan - Stock Titan
SIGA Technologies Inc Annual Shareholders Meeting Transcript - GuruFocus
Mach Natural Resources, Mesoblast and other big stocks moving lower in Tuesday's pre-market session - MSN
SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States - GlobeNewswire
SIGA (SIGA) Q1 2026 Earnings Call Transcript - AOL.com
SIGA Technologies (SIGA) Holds Steady Near Support Amid Low VolatilityLast Point Resistance - The Legal Advocate
SIGA Q1 2026 Earnings: Net Loss Reported Amid No Revenue; Stock DeclinesPositive Surprise Momentum - newsline.com
Siga Technologies Inc. (SIGA) Outpaces Stock Market Gains: What You Should Know - MSN
Why Some Penny Stocks Are Gaining Market Credibility? - Kalkine Media
Discovering SIGA Technologies And 2 Other Compelling Penny Stocks - Yahoo Finance
SIGA Technologies (SIGA) Stock: Slides -2.11%, Support at $3.96 2026-05-15Social Investment Platform - newser.com
Siga Technologies Q1 earnings call highlights - MSN
SIGA Technologies (SIGA) Is Down 9.9% After Q1 Revenue Miss And Sharper Net LossWhat's Changed - Yahoo Finance
Some Investors May Be Willing To Look Past SIGA Technologies' (NASDAQ:SIGA) Soft Earnings - Yahoo Finance
We Think You Can Look Beyond SIGA Technologies' (NASDAQ:SIGA) Lackluster Earnings - simplywall.st
TradingKey - TradingKey
SIGA expects Q2 delivery of approximately $13M of oral TPOXX while targeting an FDA PEP submission in the next 12 months - MSN
SIGA Technologies Q1 2026 Results: Financials, Key Agreements, and Strategic Updates - Minichart
SIGA Technologies Secures International TPOXX Order Amid Growth Strategy - HarianBasis.co
Siga Technologies Earnings Call: Cash-Rich, Orders Ahead - The Globe and Mail
Siga Technologies Q1 Earnings Call Highlights - MarketBeat
SIGA Technologies Q1 2026 Earnings: Minimal Deliveries, $13M TPOXX Order Expected in Q2News and Statistics - IndexBox
Q1 2026 SIGA Technologies Inc Earnings Call Transcript - GuruFocus
SIGA Technologies Inc. (SIGA) Stock Analysis: Assessing Opportunities in the Health Security Sector - DirectorsTalk Interviews
The critical factors shaping SIGA Technologies (SIGA) future (+0.64%) 2026-05-08Value Ideas - newser.com
Earnings call transcript: SIGA Technologies reports Q1 2026 loss, anticipates Q2 revenue boost - Investing.com
SIGA Technologies, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
SIGA Technologies : Management Presentation (May 2026) - marketscreener.com
SIGA (SIGA) Q1 2026 Earnings Call Transcript - The Motley Fool
SIGA Technologies (NASDAQ: SIGA) Q1 loss, dividend and mpox label change - Stock Titan
$39M in TPOXX shipments ahead as SIGA posts quarterly loss - Stock Titan
SIGA: Q1 2026 revenue declined and net loss widened, but large TPOXX deliveries and global expansion are underway - TradingView
SIGA (NASDAQ: SIGA) Q1 2026 revenue falls as net loss widens - Stock Titan
SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update - marketscreener.com
SIGA Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
SIGA CEO, CFO to discuss Q1 results and business update May 7 - Stock Titan
Lobbying Update: $80,000 of SIGA TECHNOLOGIES lobbying was just disclosed - Quiver Quantitative
SIGA Technologies (SIGA.US) will release its earnings report after the market closes on May 7. - Moomoo
SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results - marketscreener.com
Investors Purchase High Volume of Call Options on Siga Technologies (NASDAQ:SIGA) - MarketBeat
SIGA mpox therapy no longer recommended in EU - MSN
[ARS] SIGA TECHNOLOGIES INC SEC Filing - Stock Titan
SIGA Technologies (SIGA) details 2026 virtual meeting, pay and plan votes - Stock Titan
Siga Technologies Inc Stock (SIGA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Siga Technologies Inc Stock (SIGA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Luckshire Daniel J | Executive VP & CFO |
Mar 13 '26 |
Option Exercise |
0.00 |
11,503 |
0 |
286,567 |
| Hruby Dennis E | EVP & Chief Scientific Officer |
Mar 13 '26 |
Option Exercise |
0.00 |
11,445 |
0 |
202,492 |
| Miller Larry R. | General Counsel |
Mar 13 '26 |
Option Exercise |
0.00 |
21,261 |
0 |
59,705 |
| Nguyen Diem | Chief Executive Officer |
Mar 13 '26 |
Option Exercise |
0.00 |
85,045 |
0 |
185,796 |
| Nguyen Diem | Chief Executive Officer |
Jan 27 '26 |
Option Exercise |
0.00 |
55,902 |
0 |
123,555 |
| Luckshire Daniel J | Executive VP & CFO |
Jul 01 '25 |
Option Exercise |
0.00 |
24,193 |
0 |
287,410 |
| Hruby Dennis E | EVP & Chief Scientific Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
32,258 |
0 |
201,514 |
2.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):